Lara Sullivan, M.D.

Lara Sullivan, M.D.

Former President, Chief Executive Officer and Chief Medical OfficeratPyxis Oncology· In proxies 2022–2025

Pay in FY2025-76% from the year before · Pyxis Oncology stock -26.3% the same year

Lara Sullivan, M.D. was paid $1.7M in FY2025 (Dec), down 76%. Pyxis Oncology stock fell 26.3% that year.

Pay$100 in the stock at the end of FY21 → $10
Pay is from the Summary Compensation Table of each Pyxis Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Pyxis OncologyPublic company · 4 yr
    • Former President, Chief Executive Officer and Chief Medical Officer2022 – Present · 4 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?